"Promising Results: CRISPR Offers Hope for High Cholesterol Treatment"

Preliminary results from a study involving 10 patients with a genetic condition that causes high cholesterol have shown that gene-editing technology can significantly reduce levels of "bad cholesterol." The experimental treatment, which uses CRISPR base-editing to target a gene called PCSK9, needs further testing to confirm its safety and effectiveness. If successful, this approach could provide a new way to prevent heart attacks and strokes. However, some scientists remain cautious, citing uncertainties about long-term safety and potential unintended genetic changes. Gene-editing holds promise for treating various genetic diseases, but concerns about off-target effects and high costs remain.